Skip to main content
Home

Dermatologieportal

Main navigation

  • Dermatologieportal
    • Digest
    • Huidinfecties
    • Inflammatoire Huidziekten
    • Oncologie
    • Overig
  • Medi-Access
background_placeholder
PMLiVE

Articles about PMLiVE

     
Kies meer
PMLiVE
In Trending

Dermavant’s Vtama receives FDA approval for plaque psoriasis

PMLiVE
In Trending

AstraZeneca’s Saphnelo approved in Europe, the US, Japan and Canada

PMLiVE
In Wetenschap

EORTC and Pierre Fabre launch phase 3 trial for melanoma

PMLiVE
In Wetenschap

Almirall launches Actinic Keratosis Global Day during Skin Cancer Awar...

PMLiVE
In Wetenschap

Almirall and Evotec team up in multi-target dermatology alliance

PMLiVE
In Trending

Bristol Myers Squibb releases positive trial results for plaque psoria...

PMLiVE
In Trending

Amgen’s biosimilar delivers impressive phase 3 results for psoriasis c...

PMLiVE
In Trending

AbbVie’s Rinvoq accepted by SMC for atopic dermatitis

Trending

Er zijn @count nieuwe artikelen
Friday, May 27, 2022 - 14:32Nieuw
Dermavant’s Vtama receives FDA approval for plaque psoriasis
Friday, May 27, 2022 - 14:32Nieuw
AstraZeneca’s Saphnelo approved in Europe, the US, Japan and Canada
Friday, May 27, 2022 - 14:32Nieuw
EORTC and Pierre Fabre launch phase 3 trial for melanoma
Tuesday, May 24, 2022 - 14:32 - In Wetenschap
Almirall launches Actinic Keratosis Global Day during Skin Cancer Awareness Month
Thursday, May 19, 2022 - 14:32 - In Wetenschap
Almirall and Evotec team up in multi-target dermatology alliance
Friday, May 13, 2022 - 14:32 - In Trending
Bristol Myers Squibb releases positive trial results for plaque psoriasis treatment
Wednesday, April 20, 2022 - 14:32 - In Trending
Amgen’s biosimilar delivers impressive phase 3 results for psoriasis compared to Janssen’s Stelara
Tuesday, April 12, 2022 - 14:32 - In Trending
AbbVie’s Rinvoq accepted by SMC for atopic dermatitis
Wednesday, April 6, 2022 - 14:32 - In Trending
Galderma launches Rosacea Space to raise awareness
Tuesday, March 29, 2022 - 14:32 - In Trending
Lebrikizumab achieves skin clearance in pivotal phase 3 atopic dermatitis trials

Pagination

  • 1
  • 2
  • 3
  • ›› Next page
  • » Last page

Kies uw tags

e
dermatitis
eczema
psoriasis
erythema
rosacea
melanoma
skin cancer

Medzine logo gekleurd

Laatste ontwikkelingen binnen dermatologie.

Sitemap

  • Trending
  • Wetenschappelijk
  • Uw nieuws

Support

  • Contact
  • Privacyverklaring
  • Gebruik van cookies

Medix

FTO

CEFI

 CME Academy

FarmacoTherapie Online

Medi-Access